Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
Price Target
Average
123.04%
Revenue Forecast
Estimate
23.57%
EBIT
Estimate
--29.53%
Net Income
Estimate
19.22%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Denali Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for DNLI of $34.6 , with forecasts ranging from
a
low of
$22 to a high of $46 .
DNLI Lowest Price Target
Wall Street Target
22 USD
41.94%
DNLI Average Price Target
Wall Street Target
34.6 USD
123.04%
DNLI Highest Price Target
Wall Street Target
46 USD
196.77%
REVENUE FORECAST
Revenue Forecast Chart DNLI
EBIT FORECAST
EBIT Forecast Chart DNLI
NET INCOME FORECAST
Net Income Chart DNLI